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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant public health problem and treatment chal-
lenge.
Objectives: This study was conducted to determine the frequency, molecular types, and drug resistance of S. aureus isolated from
nasal carriers in two teaching hospitals (Hajar and Kashani) in Shahrekord, southwestern Iran.
Methods: In this cross-sectional study, 262 nasal specimens were obtained from healthcare staff. The disk-diffusion method was
used to detect MRSA. Nine antibiotic disks were used to determine the antibiotic susceptibility pattern. Staphylococcal cassette chro-
mosome mec (SCCmec) types were identified by the multiplex polymerase chain reaction (PCR). The data analysis was performed
using Fisher’s exact test with SPSS software.
Results: Forty-eight (18.8%) specimens were identified as S. aureus, of which 30 (11.45%) specimens were methicillin resistant. The
nasal colonization rate of the MRSA isolates was not associated with age or gender (P > 0.05). The highest resistance (33%) recorded
was to rifampin, and all the isolates were susceptible to quinupristin-dalfopristin, vancomycin, and linezolid. The SCCmec results
showed that 16.7%, 6.7%, 20%, and 56.6% of MRSA isolates were types I, II, III, and IV, respectively.
Conclusions: Nasal isolates of MRSA were prevalent among hospital staff. The highest level of resistance was to rifampin, and all
the isolates were susceptible to quinupristin-dalfopristin, vancomycin, and linezolid. SCCmec type 4 was the most frequent MRSA
isolate.
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1. Background
Many species of pathogenic bacteria, including Staphy-
lococcus aureus, have become antibiotic resistant. The
potential of S. aureus to develop resistance rapidly to
many antibiotics has led to the emergence of methicillin-
resistant S. aureus (MRSA) (1, 2). Methicillin resistance is as-
sociated with the production of the PBP2a protein by the
mecA gene. This gene is located on a 30 - 50 kb chromo-
somal DNA fragment, which is present in resistant strains
but absent in susceptible ones (2, 3). The staphylococcal
cassette chromosome mec (SCCmec) is a mobile genetic
element that carries the mecA gene and other antibiotic-
resistant genes in MRSA strains (4, 5). Staphylococcal cas-
sette chromosome mec typing is performed to identify and
differentiate community-associated MRSA infections from
healthcare-associated ones. Staphylococcal cassette chro-
mosome mec typing has been widely used to identify sev-
eral subtypes or variants of the main SCCmec types. Staphy-
lococcal cassette chromosome mec typing using the multi-
plex polymerase chain reaction (PCR) is a simple method
that can be applied in clinical microbiology laboratories
(6, 7).
Approximately 44% of nosocomial infections world-
wide are estimated to be due to MRSA (8). Moreover,
MRSA is associated with excessively high healthcare costs
in many countries. For example, annual costs to deal with
the consequences of MRSA in the U.S. are estimated at over
13.8-billion dollars (9, 10). The prevalence of MRSA contin-
ues to increase among healthcare staff, with a high rate of
nasal colonization by MRSA reported (11). Methicillin resis-
tant S. aureus can be transmitted via the skin and hands of
healthcare staff through the nostrils and lead to infection
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in
noncommercial usages, provided the original work is properly cited.
Taghaddosi R et al.
and a variety of complications in patients (12). MRSA infec-
tion can result in severe complications, such as endocardi-
tis, septicemia, pneumonia, and osteomyelitis (13-15).
Restrictions placed on drug treatment due to MRSA
have made it more difficult to combat nosocomial and
community-acquired infections (16-18). The transmission
of MRSA to patients via the hands or nostrils of health-
care staff can result in hospitalized patients experiencing
major problems (19). Methicillin resistant S. aureus infec-
tions among healthcare staff remain high, and the treat-
ment and hospitalization costs of MRSA-infected patients
are enormous. Therefore, strategies to control the spread
of MRSA are needed (20). Given the importance of the pre-
vention and treatment of nosocomial infections, data are
needed on the incidence rate, prevalence, antibiotic resis-
tance, and bacterial typing of MRSA.
2. Objectives
This study was conducted to determine the frequency,
molecular types, and drug resistance of S. aureus nasal iso-
lates in two teaching hospitals in Iran using PCR and disk-
diffusion methods.
3. Methods
3.1. Specimen Collection and Bacterial Identification
After obtaining ethical approval for the study from the
ethics committee of Shahrekord University of Medical Sci-
ences (Grant No. 1184), 262 people were enrolled in the
study: 149 staff from Kashani hospital and 113 staff from
Hajar hospital. The occupational categories consisted of
physicians, nurses, health workers, technicians, adminis-
trative staff, and service personnel from the surgical ward,
intensive care unit, kitchen, and laundry room.
To ensure qualitative and quantitative standardization
in the study, one individual collected all the samples and
recorded the data. The nasal specimens were collected
from the anterior nares of the participants using labeled
sterile cotton wool swabs. The specimens were immedi-
ately transferred to trypticase soy broth medium and in-
cubated at 37°C for 24 hours. The specimens were cul-
tured in blood agar and mannitol salt agar media (Hi Me-
dia, India) in the laboratory. If the colony became yel-
low in the mannitol salt agar medium, gram staining
was conducted. To differentiate Staphylococcus spp. in
gram-positive cluster-forming cocci, catalase and coagu-
lase (with rabbit plasma) production tests were conducted,
as well as DNase activity tests on DNase agar (Hi Media,
India) and novobiocin susceptibility tests (21, 22). To de-
tect MRSA isolates, oxacillin (1 µg) disk (Hi Media, India)
diffusion testing was performed. To determine the an-
tibiotic susceptibility of the isolates, eight antibiotic disks
(gentamicin, linezolid, vancomycin, rifampin, novobiocin,
ticoplanin, tigecycline, and quinopristin-dalfopristin) ob-
tained from Hi Media (India) were tested using the Kir-
by–Bauer disk-diffusion method (23).
3.2. DNA Extraction
Total DNA was extracted from the bacteria that grew
on the culture media with a genomic DNA purification kit
(CinnaGen Co., Iran, according to the manufacturer’s in-
structions. The quality of the extracted DNA was measured
at 260 nm wavelength according to Sambrook and Rus-
sell’s method (24). The extracted DNA was stored at -20° C
for later use.
3.3. Multiplex PCR Assay for Assignment of the mec Element Type
A multiplex PCR assay was used to identify the MRSA
isolates. The multiplex PCR method is a rapid, accurate,
and useful assay to detect the mecA gene in MRSA strains,
particularly in a hospital setting (25).
The multiplex PCR included eight loci, A-H, selected
based on mec element sequences (Table 1) (26). The mecA
gene was also included in this protocol. The PCR reactions
were conducted in a total volume of 25 µL containing the
following: 2 µL of DNA sample, 2.5 µl of 10× PCR buffer, 2
µL of mixed dNTP, 2.5 µL of MgCl2, 0.5 µL of DNA Taq poly-
merase, and 0.5µL of primers A and D for type I; primers B,
C, D, and G for type II; primers C, E, F, and H for type III, and
primers D and I for type IV. The PCR assay was performed
in a DNA Thermal Cycler 480 (Applied Biosystems, U.S.) us-
ing the following parameters: denaturation for 5 min at
95°C; 35 cycles of 94°C for 45 seconds, 53°C for 40 seconds,
and 72°C for 1 minutes, followed by a final extension for
7 minutes at 72°C. For type IV, the annealing temperature
was 52°C for 50 seconds. The PCR products then underwent
polyacrylamide gel (8%) electrophoresis and staining with
silver nitrate.
3.4. Statistical Analysis
The data were analyzed using Fisher’s exact test with
SPSS, version 16 (SPSS Inc., U.S.). The level of significance was
considered as 0.05.
4. Results
In total, the presence of MRSA in 262 samples was
tested. Of the 148 samples from Kashani hospital, 76 (51%)
were from males. Of the 114 samples from Hajar hospital,
48 (43%) were from males. Fisher’s exact test indicated no
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Table 1. Primers Used in the Multiplex Polymerase Chain Reactiona
Locus Primer Oligonucleotide Sequence (5’ - 3’) Location Amplicon Size, bp Specificity, SCCmec
Type
A
CIF2 F2 TTCGAGTTGCTGATGAAGAAGG 18398 - 18419b
495 I
CIF2 R2 ATTTACCACAAGGACTACCAGC 18892 - 18871b
B
KDP F1 AATCATCTGCCATTGGTGATGC 10445 - 10467c
284 II
KDP R1 CGAATGAAGTGAAAGAAAGTGG 10728 - 10707c
C
MECI P2 ATCAAGACTTGCATTCAGGC 42428 - 42447c
209 II, III
MECI P3 GCGGTTTCAATTCACTTGTC 42636 - 42617c
D
DCS F2 CATCCTATGATAGCTTGGTC 38011 - 37992b
342 I, II, IV
DCS R1 CTAAATCATAGCCATGACCG 37670 - 37689b
E
RIF4 F3 GTGATTGTTCGAGATATGTGG 45587 - 45607d
243 III
RIF4 R9 CGCTTTATCTGTATCTATCGC 45829 - 45809d
F
RIF5 F10 TTCTTAAGTACACGCTGAATCG 59573 - 59594d
414 III
RIF5 R13 GTCACAGTAATTCCATCAATGC 59986 - 59965d
G
IS431 P4 CAGGTCTCTTCAGATCTACG 49963 - 49982c
381 II
pUB110 R1 GAGCCATAAACACCAATAGCC 50343 - 50323c
H
IS431 P4 CAGGTCTCTTCAGATCTACG 29654 - 29673d
303 III
pT181 R1 GAAGAATGGGGAAAGCTTCAC 29976 - 29956d
mecA
MECA P4 TCCAGATTACAACTTCACCAGG 1190 - 1211e
162 Internal control
MECA P7 CCACTTCATATCTTGTAACG 1351 - 1332e
aLoci G and H were included to distinguish variants IA from I and IIIA from III, respectively.
bRelative to accession No. AB033763, SCCmec type I
cRelative to accession No. D86934, SCCmec type II
dRelative to accession No. AB037671, SCCmec type III
eRelative to accession No. Y00688, mecA gene
significant association between gender and the coloniza-
tion rate of the MRSA isolates (P = 0.218). The mean age of
the participants from Hajar and Kashani hospitals was 31.5
± 20 and 32 ± 12 (range: 21 - 51 and 21 - 45) years, respec-
tively. In addition, Fisher’s exact test indicated no signifi-
cant association between age and the colonization rate of
the MRSA isolates (P = 0.658). The proportion, age, and gen-
der of the S. aureus-positive participants are shown in Table
2.
Nineteen of the 148 (12.8%) isolates from Kashani hospi-
tal were identified as S. aureus, of which 12 (63% [8% of to-
tal isolates]) were MRSA. In Hajar hospital, 29 of the 114 iso-
lates were identified as S. aureus, of which 18 (62% [15.7% of
total isolates]) were MRSA (Figure 1). Based on a coagulase-
positive test, S. aureus was detected in 48 samples (18%).
In the oxacillin disk-diffusion test of the methicillin resis-
tance of the coagulase-positive isolates, 30 of the 48 S. au-
reus isolates were MRSA.
To determine the prevalence of MRSA carriers among
staff with different occupations in the hospitals, the partic-
ipants were divided into three groups (physicians, nurses,
and nontreatment). The latter consisted of service person-
nel, kitchen staff, office staff (secretaries and administra-
tors), and guardians. In Hajar hospital, nurses (50%) ac-
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Figure 1. Prevalence of Methicillin-Resistant Staphylococcus aureus in Each Hospital
counted for the highest proportion of carriers, and non-
treatment staff accounted for the lowest proportion (22%).
In Kashani hospital, nurses also comprised the highest
proportion (41%) of carriers, and nontreatment staff com-
prised the lowest proportion (8%).
According to the antibiotic susceptibility analysis, the
highest resistance obtained was to rifampin (33%), and all
the isolates were susceptible to quinupristin-dalfopristin
vancomycin, and linezolid. Table 3 summarizes the an-
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Table 2. Demographic Characteristics of the Methicillin-Resistant Staphylococcus aureus-Positive Participants
Variable Gender Age
Group Female Male ≤ 50 > 50
Frequency 18 30 42 6
% 37.5 62.5 87.5 12.5
tibiotic susceptibility pattern of the MRSA isolates. The
mecA gene was detected in all the MRSA isolates by the PCR.
The results of SCCmec typing based on the multiplex PCR
method showed that of 30 tested isolates, five (16.7%) were
type I, two (6.7%) were type II, six (20%) were type III, and sev-
enteen (56.6%) were type IV MRSA (Figure 2). Figure 3 shows
the SCCmec types of methicillin-resistant isolates detected
in the two hospitals.
5. Discussion
The present study was conducted to determine the fre-
quency and molecular types of MRSA isolated from nasal
carriers in teaching hospitals in Shahrekord. In this study,
48 of 262 (18%) samples were identified as S. aureus, of
which 30 (11.45%) were MRSA. In different studies of nasal
samples obtained from healthcare staff, the prevalence of
MRSA was reported to be 6.2%, 12.7%, 13.95%, 14.3%, 6.7%, and
18% in France, Ethiopia, Pakistan, India, and Saudi Arabia,
respectively (27-32). Various prevalence rates (5.3 - 53.8%)
of MRSA have been reported for Staphylococcus species iso-
lated from individuals in different regions of Iran and from
individuals in different occupations (33, 34). The different
prevalence rates of this pathogen can be attributed to dis-
similarities in healthcare policies (pattern of medication
use), sample collection, nosocomial infection control, and
the performance, education, and adherence of healthcare
staff to hygiene-related recommendations, all of which po-
tentially contribute to the distribution of resistant strains,
including MRSA (30, 35-39).
In the present study, the colonization rate of MRSA iso-
lates was not associated with age or gender. A previous
study of the prevalence and antibiotic susceptibility pat-
tern of nasal samples obtained from hospital staff and an-
alyzed using the PCR method also found no significant dif-
ference in the carriage of this pathogen according to age
and gender (33). However, Diawara et al. reported that
age was significantly associated with being a carrier of
this pathogen (40). Gebreyesus et al. demonstrated that
women were more frequent carriers of the pathogen than
men and that this finding was statistically significant (41).
Several factors, such as the methodology of the study and
occupational setting, may have contributed to these asso-
ciations.
Nurses comprised 50% of the MRSA carriers in the
present study. In other studies, nurses were also reported
to be the most frequent carriers of MRSA (30, 32, 41, 42).
The fact that nurses have more frequent contact with pa-
tients than other healthcare staff do and that they provide
care to patients in different wards throughout the hospi-
tal likely explains this finding. As a result, nurses may have
a greater risk than other staff of acquiring community-
acquired MRSA. Therefore, the higher rate of MRSA acquisi-
tion among the nurses in the present study is not surpris-
ing.
Among methicillin-resistant isolates, the highest resis-
tance was to rifampin, and all the isolates were suscep-
tible to quinipristin-dalfupristine, vancomycin, and lin-
zolid. In a previous study, 64.1% of MRSA isolates were re-
sistant to amikacin, and 76.92%, 51.28%, 87.18%, 71.8%, 10.26%,
5.13%, 89.74%, and 61.54% were resistant to ceftriaxone,
ciprofloxacin, erythromycin, gentamicin, mupirocin, ri-
fampin, tetracycline, and tobramycin, respectively (43). In
the same study, all the MRSA and methicillin-susceptible
S. aureus isolates were susceptible to fusidic acid, line-
zolid, teicoplanin, tigecycline, and vancomycin (43). In
another study, MRSA isolates also appeared to exhibit
high sensitivity to vancomycin, teicoplanin, and trimetho-
prim/sulfamethoxazole (44). Various factors, such as age,
duration of treatment, and geographical region, have been
shown to contribute to MRSA drug resistance (36, 45, 46).
The results of the SCCmec typing in the present study
demonstrated that 16.7% of MRSA isolates were type I, 6.7%
were type II, 20% were type III, and 56.6% were type IV.
In a study of specimens obtained in a hospital setting,
a PCR analysis revealed that SCCmec type I was the most
frequent type (58.9%), followed by SCCmec type II (19.9%),
type III (11.0%), and type IV (8.2%) (35). In another study,
most isolates were SCCmec types II and IV (47). In a study
of isolates obtained from healthcare staff, approximately
half the specimens were types IVa and V, and no specimens
were type I (48).
The prevalence of MRSA among healthcare staff in the
two hospitals in southwestern Iran varied, and the esti-
mated prevalence was lower than average. The findings
indicated that the MRSA isolates showed the highest re-
sistance to rifampin and that all the isolates were suscep-
tible to quinipristin-dalfupristine, vancomycin, and lin-
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Table 3. Antibiotic Susceptibility Pattern of Methicillin-Resistant Staphylococcus aureus Isolates
Antibiotic Susceptible, No. (%) Intermediate, No. (%) Resistant, No. (%)
Bacitracin, 10µg 24 (80) 0 6 (20)
Gentamycin, 10µg 26 (86.7) 0 4 (13.3)
Novobiocin, 30µg 25 (83) 1 (3) 4 (13.3)
Ticoplanin, 30µg 18 (60) 5 (17) 7 (23)
Linezolid, 30µg 30 (100) 0 0
Quinupristin-dalfopristin, 15µg 30 (100) 0 0
Tigecycline, 15µg 17 (56.7) 4 (13.3) 9 (30)
Rifampin, 5µg 19 (63.4) 1 (3.3) 10 (33.3)
Vancomycin, 30µg 30 (100) 0 0
Figure 2. View of the Stained Polyacrylamide Gel Showing Staphylococcal Cassette Chromosome mec (SCCmec) Types I-IV
From left to right, first lane, DNA marker; lane A1, standard SCCmec type 1; lane A2, SCCmec type 1; lane A3, standard SCCmec type 2; lanes A4 and A5, SCCmec type 2; lane A6,
standard SCCmec type 3; lanes A7 to A10, SCCmec type 3; lane A11, standard SCCmec type IV; lanes A12 to A17, SCCmec type IV.
zolid. SCCmec type IV was the most prevalent MRSA iso-
late. Given the growth in the resistance of these bacteria to
antibiotics, including methicillin, implementing plans to
detect, control, and restrict carriers of MRSA, particularly
healthcare staff who are in direct contact with patients, is
vital to prevent the transmission of MRSA isolates to hospi-
talized patients.
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